Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Discrimination
  • EEG
  • Premature Neonates
  • Time Perception
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Diagnostic

Participation Requirements

Age
Younger than 1 years
Gender
Both males and females

Description

Neurodevelopmental disorders may be related to functional or structural disruption of the neuronal network organization at an early stage or later in the course of development. The disruption of the initial set-up could partially explain the prevalence of neurodevelopmental risks due to prematurity....

Neurodevelopmental disorders may be related to functional or structural disruption of the neuronal network organization at an early stage or later in the course of development. The disruption of the initial set-up could partially explain the prevalence of neurodevelopmental risks due to prematurity. The development period between 25 and 33 wGA corresponds to the period of very great prematurity and represents a key period of neurodevelopment in terms of structural and functional establishment of neuronal networks. One way to address the functionality of the neuronal networks is to evaluate the neural response to the exogenous stimuli and to interpret the mechanisms and the developmental status of the network in their ability to develop appropriate responses.

Tracking Information

NCT #
NCT04270734
Collaborators
Not Provided
Investigators
Principal Investigator: Ghilda Ghostine, MD CHU Amiens Principal Investigator: Guy Kongolo, MD CHU Amiens Principal Investigator: Sabrina Goudjil, MD CHU Amiens Principal Investigator: André Léké, MD CHU Amiens Principal Investigator: Christèle Chazal, MD CHU Amiens Principal Investigator: Pierre Tourneux, Pr CHU Amiens Principal Investigator: Coralie Degorre, MD CHU Amiens Principal Investigator: Emilie Bourel, MD CHU Amiens Principal Investigator: Laura Routier, MD CHU Amiens Principal Investigator: Claire Héberlé, MD CHU Amiens